Back to search

Boston University

CRISPR/Cas13 based biosensing of miRNA-21 as a diagnostic biomarker for Alzheimer's disease

Abstract

dc:description.abstract

Alzheimer’s Disease is one of the most prevalent neurodegenerative diseases affecting the elderly population, with approximately 65 million individuals diagnosed worldwide. The hallmark pathological features include the accumulation of Aß senile plaques and the hyperphosphorylation of tau protein, ultimately leading to memory loss, cognitive deficits and loss of executive function. Due to its rapid progression and the inability to diagnose in early stages, mechanisms for detection and target biomarkers for AD have been well under study. In recent years, small extracellular vesicles, also known as exosomes, which contain a variety of macromolecules: protein, RNA, lipids and other metabolites, have been capable of acting as biomarkers for a wide variety of cancers and other diseases due to their ability to reflect the physiological status of the origin cell. This study will aim to characterize the presence of microRNA-21, a potential biomarker for AD, in SH-SY5Y neuroblastomal-derived exosomes using the CRISPR/Cas13 (Clustered Regularly Interspaced Short Palindromic Repeats) platform for diagnostic assay.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Medical Sciences
Grantor
Boston University
Year dc:date.issued
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Zara, Annelisse
Advisors dc:contributor.advisor
  • Lee, Ki-Bum
  • Roussarie, Jean-Pierre

Subjects

dc:subject × 2

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/51712

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Zara, Annelisse. CRISPR/Cas13 based biosensing of miRNA-21 as a diagnostic biomarker for Alzheimer's disease. masters thesis, Boston University, 2024. https://hdl.handle.net/2144/51712